HEART FAILURE
Clinical trials for HEART FAILURE explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE trials appear
Sign up with your email to follow new studies for HEART FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart-Kidney drug study halted after just 8 patients
Disease control TerminatedThis study tested whether adding a new drug called AZD5462 to standard treatment (dapagliflozin) could help people with both heart failure and moderate kidney disease. The goal was to see how the combination affected sodium excretion and other health markers. Only 8 participants …
Matched conditions: HEART FAILURE
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Heart failure drug trial halted midway
Disease control TerminatedThis study tested a single dose of an experimental drug called REGN5381 in 89 people with chronic heart failure whose hearts pump less blood than normal. The goal was to check safety, side effects, and how the drug affects heart stress markers. The study was terminated early, so …
Matched conditions: HEART FAILURE
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New heart failure drug shows promise in early trial
Disease control TerminatedThis study tested a new medicine called XXB750 in 136 people with heart failure and reduced heart pumping ability. The goal was to see if the drug could lower a key stress marker in the blood and improve symptoms. The trial was stopped early, but the results help researchers unde…
Matched conditions: HEART FAILURE
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
Mini heart pump trial halted early, but shows promise for advanced heart failure
Disease control TerminatedThis study tested a small heart pump called the HeartWare MVAD in 11 people with severe heart failure. The goal was to see if the device is safe and helps patients live longer. The trial was stopped early, but it measured how many patients survived for 6 months and 2 years.
Matched conditions: HEART FAILURE
Phase: NA • Sponsor: Medtronic Cardiac Rhythm and Heart Failure • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
New heart failure drug trial halted midway – what we know
Disease control TerminatedThis study tested an experimental drug called LY3540378 in adults with worsening chronic heart failure where the heart pumps normally but doesn't fill properly (HFpEF). The goal was to see if the drug could improve heart function and safety. About 332 people were planned to join,…
Matched conditions: HEART FAILURE
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
Heart failure drug trial halted: did ponsegromab ease symptoms?
Symptom relief TerminatedThis study tested whether a medicine called Ponsegromab could improve symptoms and quality of life in adults with heart failure. Participants received either the drug or a placebo as a shot every four weeks for about 9 months. The trial was stopped early, so results are limited. …
Matched conditions: HEART FAILURE
Phase: PHASE2 • Sponsor: Pfizer • Aim: Symptom relief
Last updated May 17, 2026 04:17 UTC
-
Heart surgery recovery: can patients safely ditch strict precautions?
Symptom relief TerminatedThis study tested whether letting heart surgery patients manage their own recovery (self-managed sternal precautions) leads to better quality of life than following standard strict precautions. Researchers enrolled 10 adults who had chest-opening heart surgery and tracked pain, r…
Matched conditions: HEART FAILURE
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC
-
Wearable Defibrillator's heart sound accuracy under review
Knowledge-focused TerminatedThis study looked at how well a wearable defibrillator (WCD) records heart sounds compared to a standard device. It involved 60 adults with heart failure and weak heart pumping. The goal was to see if the WCD's recordings are accurate enough for monitoring.
Matched conditions: HEART FAILURE
Sponsor: Zoll Medical Corporation • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Smart patch aims to predict heart failure Flare-Ups
Knowledge-focused TerminatedThis study tested a special wearable patch that tracks health signals in people with heart failure. The goal was to see if the patch could warn doctors before a patient needs to go to the hospital. About 13 adults who had recently been hospitalized for heart failure took part. Th…
Matched conditions: HEART FAILURE
Sponsor: Nanowear Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC
-
Which pacemaker setting boosts blood pressure best in heart failure?
Knowledge-focused TerminatedThis study looked at people with heart failure who had a special pacemaker (CRT) implanted. The goal was to see which of three pacing modes gave the best immediate boost in blood pressure. The study was stopped early, but it aimed to help doctors choose the best settings for each…
Matched conditions: HEART FAILURE
Phase: NA • Sponsor: CMC Ambroise Paré • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC